Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Modified sialic acids on mucus and erythrocytes inhibit influenza A HA and NA functions.

Barnard KN, Alford-Lawrence BK, Buchholz DW, Wasik BR, LaClair JR, Yu H, Honce R, Ruhl S, Pajic P, Daugherity EK, Chen X, Schultz-Cherry SL, Aguilar HC, Varki A, Parrish CR.

J Virol. 2020 Feb 12. pii: JVI.01567-19. doi: 10.1128/JVI.01567-19. [Epub ahead of print]

PMID:
32051275
2.

Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials.

Poordad F, Castro RE, Asatryan A, Aguilar H, Cacoub P, Dieterich D, Marinho RT, Carvalho A, Siddique A, Hu YB, Charafeddine M, Bondin M, Khan N, Cohen DE, Felizarta F.

J Viral Hepat. 2020 May;27(5):497-504. doi: 10.1111/jvh.13261. Epub 2020 Feb 17.

PMID:
31954087
3.

Case 273: Pancreatic Duct-to-Portal Vein Fistula with Secondary Portal Vein Pyophlebitis-A Rare Complication of Chronic Pancreatitis.

Aguilar HN, Manolea F, Patel VH, Low G.

Radiology. 2020 Jan;294(1):234-237. doi: 10.1148/radiol.2019171373.

PMID:
31846410
4.

Expression of 9-O- and 7,9-O-Acetyl Modified Sialic Acid in Cells and Their Effects on Influenza Viruses.

Barnard KN, Wasik BR, LaClair JR, Buchholz DW, Weichert WS, Alford-Lawrence BK, Aguilar HC, Parrish CR.

mBio. 2019 Dec 3;10(6). pii: e02490-19. doi: 10.1128/mBio.02490-19.

5.

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial.

Brown RS Jr, Buti M, Rodrigues L, Chulanov V, Chuang WL, Aguilar H, Horváth G, Zuckerman E, Carrion BR, Rodriguez-Perez F, Urbánek P, Abergel A, Cohen E, Lovell SS, Schnell G, Lin CW, Zha J, Wang S, Trinh R, Mensa FJ, Burroughs M, Felizarta F.

J Hepatol. 2020 Mar;72(3):441-449. doi: 10.1016/j.jhep.2019.10.020. Epub 2019 Nov 2.

6.

Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound.

Sam M, Raubenheimer M, Manolea F, Aguilar H, Mathew RP, Patel VH, Low G.

Abdom Radiol (NY). 2020 Mar;45(3):842-850. doi: 10.1007/s00261-019-02231-9.

PMID:
31552462
7.

Nipah Virus-Like Particle Egress Is Modulated by Cytoskeletal and Vesicular Trafficking Pathways: a Validated Particle Proteomics Analysis.

Johnston GP, Bradel-Tretheway B, Piehowski PD, Brewer HM, Lee BNR, Usher NT, Zamora JLR, Ortega V, Contreras EM, Teuton JR, Wendler JP, Matz KM, Adkins JN, Aguilar HC.

mSystems. 2019 Sep 24;4(5). pii: e00194-19. doi: 10.1128/mSystems.00194-19.

8.

Case 273.

Aguilar HN, Manolea F, Patel VH, Low G.

Radiology. 2019 Sep;292(3):773-775. doi: 10.1148/radiol.2017171374.

PMID:
31437113
9.

A New Method for Securing Dermal Substitutes and Skin Grafts to Difficult Portions of the Face Using a Custom 3D-Printed Facemask.

Aguilar HA, Mayer HF.

J Burn Care Res. 2019 Oct 16;40(6):1015-1018. doi: 10.1093/jbcr/irz128.

PMID:
31290964
10.

Assessment of users' acceptability of a mobile-based embodied conversational agent for the prevention and detection of suicidal behaviour.

Martínez-Miranda J, Martínez A, Ramos R, Aguilar H, Jiménez L, Arias H, Rosales G, Valencia E.

J Med Syst. 2019 Jun 25;43(8):246. doi: 10.1007/s10916-019-1387-1.

PMID:
31240494
11.

Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.

Bradel-Tretheway BG, Zamora JLR, Stone JA, Liu Q, Li J, Aguilar HC.

J Virol. 2019 Jun 14;93(13). pii: e00577-19. doi: 10.1128/JVI.00577-19. Print 2019 Jul 1.

12.

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies.

Foster GR, Dore GJ, Wang S, Grebely J, Sherman KE, Baumgarten A, Conway B, Jackson D, Asselah T, Gschwantler M, Tomasiewicz K, Aguilar H, Asatryan A, Hu Y, Mensa FJ.

Drug Alcohol Depend. 2019 Jan 1;194:487-494. doi: 10.1016/j.drugalcdep.2018.11.007. Epub 2018 Nov 24.

PMID:
30529905
13.

Differential Regulation of Myosin Regulatory Light Chain Phosphorylation by Protein Kinase C Isozymes in Human Uterine Myocytes.

Mitchell BF, Chi M, Surgent E, Sorochan BM, Tracey CN, Aguilar HN, Mongin M, Zielnik B.

Reprod Sci. 2019 Jul;26(7):988-996. doi: 10.1177/1933719118802062. Epub 2018 Nov 14.

PMID:
30428777
14.

Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.

PLoS One. 2018 Nov 12;13(11):e0207586. doi: 10.1371/journal.pone.0207586. eCollection 2018.

15.

Broad-spectrum antiviral JL122 blocks infection and inhibits transmission of aquatic rhabdoviruses.

Balmer BF, Getchell RG, Powers RL, Lee J, Zhang T, Jung ME, Purcell MK, Snekvik K, Aguilar HC.

Virology. 2018 Dec;525:143-149. doi: 10.1016/j.virol.2018.09.009. Epub 2018 Oct 1.

16.

A stochastic assembly model for Nipah virus revealed by super-resolution microscopy.

Liu Q, Chen L, Aguilar HC, Chou KC.

Nat Commun. 2018 Aug 3;9(1):3050. doi: 10.1038/s41467-018-05480-2.

17.

Addicted to sugar: roles of glycans in the order Mononegavirales.

Ortega V, Stone JA, Contreras EM, Iorio RM, Aguilar HC.

Glycobiology. 2019 Jan 1;29(1):2-21. doi: 10.1093/glycob/cwy053.

18.

Analytical Pipeline for Discovery and Verification of Glycoproteins from Plasma-Derived Extracellular Vesicles as Breast Cancer Biomarkers.

Chen IH, Aguilar HA, Paez Paez JS, Wu X, Pan L, Wendt MK, Iliuk AB, Zhang Y, Tao WA.

Anal Chem. 2018 May 15;90(10):6307-6313. doi: 10.1021/acs.analchem.8b01090. Epub 2018 Apr 23.

PMID:
29629753
19.

Flow virometry as a tool to study viruses.

Zamora JLR, Aguilar HC.

Methods. 2018 Feb 1;134-135:87-97. doi: 10.1016/j.ymeth.2017.12.011. Epub 2017 Dec 16. Review.

20.

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.

Asselah T, Kowdley KV, Zadeikis N, Wang S, Hassanein T, Horsmans Y, Colombo M, Calinas F, Aguilar H, de Ledinghen V, Mantry PS, Hezode C, Marinho RT, Agarwal K, Nevens F, Elkhashab M, Kort J, Liu R, Ng TI, Krishnan P, Lin CW, Mensa FJ.

Clin Gastroenterol Hepatol. 2018 Mar;16(3):417-426. doi: 10.1016/j.cgh.2017.09.027. Epub 2017 Sep 22.

PMID:
28951228
21.

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.

Forns X, Lee SS, Valdes J, Lens S, Ghalib R, Aguilar H, Felizarta F, Hassanein T, Hinrichsen H, Rincon D, Morillas R, Zeuzem S, Horsmans Y, Nelson DR, Yu Y, Krishnan P, Lin CW, Kort JJ, Mensa FJ.

Lancet Infect Dis. 2017 Oct;17(10):1062-1068. doi: 10.1016/S1473-3099(17)30496-6. Epub 2017 Aug 14.

PMID:
28818546
22.

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis.

Kwo PY, Poordad F, Asatryan A, Wang S, Wyles DL, Hassanein T, Felizarta F, Sulkowski MS, Gane E, Maliakkal B, Overcash JS, Gordon SC, Muir AJ, Aguilar H, Agarwal K, Dore GJ, Lin CW, Liu R, Lovell SS, Ng TI, Kort J, Mensa FJ.

J Hepatol. 2017 Aug;67(2):263-271. doi: 10.1016/j.jhep.2017.03.039. Epub 2017 Apr 13.

PMID:
28412293
23.

MRI-based hip cartilage measures in osteoarthritic and non-osteoarthritic individuals: a systematic review.

Aguilar HN, Battié MC, Jaremko JL.

RMD Open. 2017 Mar 22;3(1):e000358. doi: 10.1136/rmdopen-2016-000358. eCollection 2017. Review.

24.

Cytoplasmic Motifs in the Nipah Virus Fusion Protein Modulate Virus Particle Assembly and Egress.

Johnston GP, Contreras EM, Dabundo J, Henderson BA, Matz KM, Ortega V, Ramirez A, Park A, Aguilar HC.

J Virol. 2017 Apr 28;91(10). pii: e02150-16. doi: 10.1128/JVI.02150-16. Print 2017 May 15.

25.

Paramyxovirus Glycoproteins and the Membrane Fusion Process.

Aguilar HC, Henderson BA, Zamora JL, Johnston GP.

Curr Clin Microbiol Rep. 2016 Sep;3(3):142-154. doi: 10.1007/s40588-016-0040-8. Epub 2016 Jul 5.

26.

Ovine Herpesvirus 2 Glycoproteins B, H, and L Are Sufficient for, and Viral Glycoprotein Ov8 Can Enhance, Cell-Cell Membrane Fusion.

AlHajri SM, Cunha CW, Nicola AV, Aguilar HC, Li H, Taus NS.

J Virol. 2017 Feb 28;91(6). pii: e02454-16. doi: 10.1128/JVI.02454-16. Print 2017 Mar 15.

27.

Mildly Acidic pH Triggers an Irreversible Conformational Change in the Fusion Domain of Herpes Simplex Virus 1 Glycoprotein B and Inactivation of Viral Entry.

Weed DJ, Pritchard SM, Gonzalez F, Aguilar HC, Nicola AV.

J Virol. 2017 Feb 14;91(5). pii: e02123-16. doi: 10.1128/JVI.02123-16. Print 2017 Mar 1.

28.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Castellà E, Nellist M, Morales S, Valls J, Velasco A, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EEW, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M, Cortés J, Lázaro C, Odero MD, Martens JWM, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA.

Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. Epub 2016 Dec 19.

29.

Mexican registry of pulmonary hypertension: REMEHIP.

Sandoval Zarate J, Jerjes-Sanchez C, Ramirez-Rivera A, Zamudio TP, Gutierrez-Fajardo P, Elizalde Gonzalez J, Leon MS, Gamez MB, Abril FM, Michel RP, Aguilar HG; REMEHIP Investigators.

Arch Cardiol Mex. 2017 Jan - Mar;87(1):13-17. doi: 10.1016/j.acmx.2016.11.006. Epub 2016 Dec 14.

PMID:
27988223
30.

Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation.

Pan L, Aguilar HA, Wang L, Iliuk A, Tao WA.

J Am Chem Soc. 2016 Nov 30;138(47):15311-15314. Epub 2016 Nov 17.

31.

Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.

Balmer BF, Powers RL, Zhang TH, Lee J, Vigant F, Lee B, Jung ME, Purcell MK, Snekvik K, Aguilar HC.

J Virol. 2017 Jan 31;91(4). pii: e02181-16. doi: 10.1128/JVI.02181-16. Print 2017 Feb 15.

32.

Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.

Stone JA, Vemulapati BM, Bradel-Tretheway B, Aguilar HC.

J Virol. 2016 Nov 14;90(23):10762-10773. doi: 10.1128/JVI.01469-16. Print 2016 Dec 1.

33.

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.

Gane E, Poordad F, Wang S, Asatryan A, Kwo PY, Lalezari J, Wyles DL, Hassanein T, Aguilar H, Maliakkal B, Liu R, Lin CW, Ng TI, Kort J, Mensa FJ.

Gastroenterology. 2016 Oct;151(4):651-659.e1. doi: 10.1053/j.gastro.2016.07.020. Epub 2016 Jul 25.

PMID:
27456384
34.

Chagas Disease Has Not Been Controlled in Ecuador.

Dumonteil E, Herrera C, Martini L, Grijalva MJ, Guevara AG, Costales JA, Aguilar HM, Brenière SF, Waleckx E.

PLoS One. 2016 Jun 28;11(6):e0158145. doi: 10.1371/journal.pone.0158145. eCollection 2016. No abstract available.

35.

Measles Virus Fusion Protein: Structure, Function and Inhibition.

Plattet P, Alves L, Herren M, Aguilar HC.

Viruses. 2016 Apr 21;8(4):112. doi: 10.3390/v8040112. Review.

36.

Multiple Novel Functions of Henipavirus O-glycans: The First O-glycan Functions Identified in the Paramyxovirus Family.

Stone JA, Nicola AV, Baum LG, Aguilar HC.

PLoS Pathog. 2016 Feb 11;12(2):e1005445. doi: 10.1371/journal.ppat.1005445. eCollection 2016 Feb.

37.

Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly.

Xu K, Chan YP, Bradel-Tretheway B, Akyol-Ataman Z, Zhu Y, Dutta S, Yan L, Feng Y, Wang LF, Skiniotis G, Lee B, Zhou ZH, Broder CC, Aguilar HC, Nikolov DB.

PLoS Pathog. 2015 Dec 8;11(12):e1005322. doi: 10.1371/journal.ppat.1005322. eCollection 2015 Dec.

38.

Polyethylene glycol-mediated fusion of herpes simplex type 1 virions with the plasma membrane of cells that support endocytic entry.

Walker EB, Pritchard SM, Cunha CW, Aguilar HC, Nicola AV.

Virol J. 2015 Nov 16;12:190. doi: 10.1186/s12985-015-0423-0.

39.

Design, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors.

Zhao Y, Yang C, Organ C, Li Z, Bhushan S, Otsuka H, Pacheco A, Kang J, Aguilar HC, Lefer DJ, Xian M.

J Med Chem. 2015 Sep 24;58(18):7501-11. doi: 10.1021/acs.jmedchem.5b01033. Epub 2015 Sep 4.

40.

Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene.

Cunha CW, Taylor KE, Pritchard SM, Delboy MG, Komala Sari T, Aguilar HC, Mossman KL, Nicola AV.

PLoS One. 2015 Jul 17;10(7):e0131129. doi: 10.1371/journal.pone.0131129. eCollection 2015.

41.

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra-Musach J, Mateo F, Aguilar H, Gómez-Baldó L, Petit A, Vidal A, Climent F, Hernández-Losa J, Cordero Á, González-Suárez E, Sánchez-Mut JV, Esteller M, Llatjós R, Varela M, López JI, García N, Extremera AI, Gumà A, Ortega R, Plà MJ, Fernández A, Pernas S, Falo C, Morilla I, Campos M, Gil M, Román A, Molina-Molina M, Ussetti P, Laporta R, Valenzuela C, Ancochea J, Xaubet A, Casanova Á, Pujana MA.

PLoS One. 2015 Jul 13;10(7):e0132546. doi: 10.1371/journal.pone.0132546. eCollection 2015. Erratum in: PLoS One. 2018 Nov 12;13(11):e0207586.

42.

Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.

Bradel-Tretheway BG, Liu Q, Stone JA, McInally S, Aguilar HC.

J Virol. 2015 Jul;89(14):7235-47. doi: 10.1128/JVI.00773-15. Epub 2015 May 6.

43.

Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.

Lalezari J, Sullivan JG, Varunok P, Galen E, Kowdley KV, Rustgi V, Aguilar H, Felizarta F, McGovern B, King M, Polepally AR, Cohen DE.

J Hepatol. 2015 Aug;63(2):364-9. doi: 10.1016/j.jhep.2015.03.029. Epub 2015 Apr 1.

44.

Branched dimerization of Tat peptide improves permeability to HeLa and hippocampal neuronal cells.

Monreal IA, Liu Q, Tyson K, Bland T, Dalisay DS, Adams EV, Wayman GA, Aguilar HC, Saludes JP.

Chem Commun (Camb). 2015 Mar 28;51(25):5463-6. doi: 10.1039/c5cc00882d.

PMID:
25733181
45.

Antibodies to ovine herpesvirus 2 glycoproteins decrease virus infectivity and prevent malignant catarrhal fever in rabbits.

Cunha CW, Knowles DP, Taus NS, O'Toole D, Nicola AV, Aguilar HC, Li H.

Vet Microbiol. 2015 Feb 25;175(2-4):349-55. doi: 10.1016/j.vetmic.2014.11.026. Epub 2014 Dec 9.

PMID:
25542288
46.

Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.

Garner OB, Yun T, Pernet O, Aguilar HC, Park A, Bowden TA, Freiberg AN, Lee B, Baum LG.

J Virol. 2015 Mar;89(5):2520-9. doi: 10.1128/JVI.02435-14. Epub 2014 Dec 10.

47.

Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.

Liu Q, Bradel-Tretheway B, Monreal AI, Saludes JP, Lu X, Nicola AV, Aguilar HC.

J Virol. 2015 Feb;89(3):1838-50. doi: 10.1128/JVI.02277-14. Epub 2014 Nov 26.

48.

Nipah virion entry kinetics, composition, and conformational changes determined by enzymatic virus-like particles and new flow virometry tools.

Landowski M, Dabundo J, Liu Q, Nicola AV, Aguilar HC.

J Virol. 2014 Dec;88(24):14197-206. doi: 10.1128/JVI.01632-14. Epub 2014 Oct 1.

49.

Molecular requirement for sterols in herpes simplex virus entry and infectivity.

Wudiri GA, Pritchard SM, Li H, Liu J, Aguilar HC, Gilk SD, Nicola AV.

J Virol. 2014 Dec;88(23):13918-22. doi: 10.1128/JVI.01615-14. Epub 2014 Sep 17.

50.

VAV3 mediates resistance to breast cancer endocrine therapy.

Aguilar H, Urruticoechea A, Halonen P, Kiyotani K, Mushiroda T, Barril X, Serra-Musach J, Islam A, Caizzi L, Di Croce L, Nevedomskaya E, Zwart W, Bostner J, Karlsson E, Pérez Tenorio G, Fornander T, Sgroi DC, Garcia-Mata R, Jansen MP, García N, Bonifaci N, Climent F, Soler MT, Rodríguez-Vida A, Gil M, Brunet J, Martrat G, Gómez-Baldó L, Extremera AI, Figueras A, Balart J, Clarke R, Burnstein KL, Carlson KE, Katzenellenbogen JA, Vizoso M, Esteller M, Villanueva A, Rodríguez-Peña AB, Bustelo XR, Nakamura Y, Zembutsu H, Stål O, Beijersbergen RL, Pujana MA.

Breast Cancer Res. 2014 May 28;16(3):R53. doi: 10.1186/bcr3664.

Supplemental Content

Loading ...
Support Center